Last Updated on February 20, 2026 by Rajat Bhati
The Securities and Exchange Board of India (SEBI) has accelerated its approval pace, and issued observations to four companies this week. These approvals, issued between 13 February 2026 and 20 February 2026, signal a healthy appetite for capital expansion across various industrial sectors. Let’s take a look of the list of new IPO approvals as on 20 Feb 2026.
Alpine Texworld IPO Approval
Alpine Texworld has cleared the regulatory path for its public debut. The company is a prominent player in the Indian textile landscape, specializing in the manufacturing and export of high-quality fabrics. Their operations are vertically integrated, spanning across weaving, processing, and finishing.
The company filed its DRHP on 30 September 2025 and received the final SEBI nod on 20 February 2026. Managed by D & A Financial Services, this IPO is structured as a fresh issue (1.50 crore shares).
Anjali Labtech IPO Approval
Anjali Labtech operates in the critical but often overlooked niche of laboratory infrastructure and scientific instrumentation. The company designs, manufactures, and installs specialized laboratory furniture, fume hoods, and high-precision equipment used in sophisticated research environments. With India’s pharmaceutical and chemical sectors investing heavily in R&D, Anjali Labtech’s role as an infrastructure provider has become increasingly vital. Their client list includes top-tier pharma innovators and government research bodies.
The company took the “Pre-filing” route—a mechanism used to maintain confidentiality during the initial review phase—filing on 6 October 2025. SEBI issued its observations on 17 February 2026, with IIFL Capital Services leading the transition. While the exact issue size will be updated in the final prospectus.
APPL Containers IPO Approval
APPL Containers is a specialized manufacturer focused on industrial packaging and container solutions. They produce intermediate bulk containers (IBCs) and high-durability drums that are essential for the safe transport of oils, chemicals, and food-grade liquids. As India’s manufacturing sector expands, the demand for standardized, safe, and durable industrial packaging has reached an all-time high. APPL has established itself as a reliable partner for large-scale industrial players who require packaging that meets stringent international safety norms.
The company’s DRHP was filed on 8 October 2025, and it received SEBI’s observation letter on 20 February 2026. This IPO is a combination of a fresh issue (12.50 lakh shares) and an Offer for Sale (25.60 lakh shares), managed by Cumulative Capital.
Integris Medtech IPO Approval
Integris Medtech is one of the more technologically advanced entries in the current IPO batch. The company develops and manufactures high-end medical devices and surgical equipment, focusing on areas like cardiology, orthopedics, and general surgery.
Integris filed its DRHP on 10 October 2025 and secured SEBI’s approval on 13 February 2026. The issue is a mix of fresh issue (INR 925 crore) and Offer for Sale (2.17 crore shares), with ICICI Securities acting as the book-running lead manager. This IPO offers a rare opportunity for investors to participate in the high-margin, technology-intensive medical device manufacturing sector, which is currently a priority area under the government’s manufacturing initiatives.